Chapter 9 - The Account Jennifer Never Knew About
Greg’s private account had opened two weeks before Leo’s implantation.
Initial deposit:
5,000 dollars from Northshore.
Then stipends.
Then transfers from Greg’s wages.
Not much.
The final 25,000 dollar payment would have pushed the balance above forty thousand.
Enough for a deposit on an apartment.
Debt negotiation.
Legal retainer.
A new start.
Jennifer stared at the records.
“He was planning to leave.”
Maybe.
There was no signed lease.
No divorce petition.
But search history showed apartments in Eugene.
Child custody lawyers.
Separate bank accounts.
One note:
After final payout, talk to Jen.
Another:
Need Leo quiet until removal.
The study and marriage timeline overlapped.
Greg did not need the money only to survive.
He needed it to exit with leverage.
Why keep Leo?
Another search:
Stepparent custody after divorce Oregon.
Could Greg obtain custody?
Not easily without legal status and specific circumstances.
He seemed to misunderstand.
Then a document appeared.
Petition draft for stepparent adoption.
Jennifer had never seen it.
Leo’s biological father was dead.
Greg could potentially seek adoption with Jennifer’s consent.
He had asked her casually one year earlier.
She said:
Maybe when Leo wants it.
Nothing proceeded.
Now Greg had a draft.
Not filed.
Why?
If he adopted Leo before separation, he would gain parental standing.
And the research contract could continue under his authority.
Jennifer looked sick.
“He was building a way to keep access to Leo.”
Maybe.
The evidence supported planning, not completed intent.
Still frightening.
Leo’s study data also had value beyond the final bonus.
NerveLine’s acquisition model assigned an internal value to completed pediatric longitudinal subjects.
N09 was marked:
High quality dataset.
Genetic continuity with legacy JT 03.
Strong stress response range.
The language reduced a child to usefulness.
Then Erin Cole identified another family.
N07’s mother, Amanda Brooks, agreed to speak voluntarily.
Her eleven year old daughter had received an arm implant.
Not cheek.
She knew about the implant.
She had signed what she thought was a legal research consent.
Her daughter developed infection after fifty two days.
Amanda insisted on removal.
Northshore withheld part of the compensation.
That was unpleasant but contractually disclosed.
Then the company threatened to charge device replacement fees if Amanda spoke publicly.
She hired an attorney.
Northshore settled the payment dispute quietly.
No admission.
Amanda never realized some parents had not received full consent information.
Her case mattered because it confirmed Northshore knew pediatric implants existed at higher levels.
General counsel Monica Vale could no longer say she had never heard of the program.
Settlement email copied her.
Monica corrected her statement.
She knew of limited pediatric use.
She believed it occurred under separate approved protocols.
Where were those approvals?
Nobody produced them.
Then NerveLine’s acquisition partner became public.
Redwood Medical Technologies.
A publicly traded device company considering purchase of NerveLine’s sensor platform.
The deal value was not 180 million.
That was Northshore’s internal acquisition option.
Redwood planned a larger transaction that could value the technology above 300 million.
Dr. Hale’s incentives became enormous.
Northshore hoped to acquire NerveLine cheaply first, then sell or partner upward.
Pediatric data strengthened the pitch.
Emails:
Hale:
Need all 12 youth datasets complete before Redwood diligence.
Kara:
N07 explanted early.
Hale:
Then 11.
Kara:
N09 infection recurring.
Hale:
Three days. Keep protocol.
Three days.
The exact time Leo had left when Thomas found the capsule.
Kara replied:
If caregiver reports fever, must remove.
Hale:
Of course.
No explicit order to ignore serious infection.
But:
Three days. Keep protocol.
That pressure moved downhill.
Kara pressured Greg.
Greg pressured Leo.
Then the final email:
Hale:
May you like
Outside ER discovery would be catastrophic.
Continue to the next part: The company’s chief scientist knew that if an outside hospital found one of the pediatric implants, the entire acquisition could unravel.
